0001562180-23-008109.txt : 20231205 0001562180-23-008109.hdr.sgml : 20231205 20231205162214 ACCESSION NUMBER: 0001562180-23-008109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quane Alessandrea C. CENTRAL INDEX KEY: 0001667819 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40154 FILM NUMBER: 231466891 MAIL ADDRESS: STREET 1: 175 WATER STREET CITY: NEW YORK STATE: NY ZIP: 10038 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oscar Health, Inc. CENTRAL INDEX KEY: 0001568651 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 403-3677 MAIL ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: Mulberry Health Inc. DATE OF NAME CHANGE: 20130204 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-12-01 false 0001568651 Oscar Health, Inc. OSCR 0001667819 Quane Alessandrea C. 75 VARICK STREET, 5TH FLOOR NEW YORK NY 10013 false true false false EVP, Chief Insurance Officer false Class A Common Stock 2023-12-01 4 M false 7016.00 A 274633.00 D Class A Common Stock 2023-12-01 4 M false 34379.00 A 309012.00 D Class A Common Stock 2023-12-04 4 S false 22246.00 8.34 D 286766.00 D Restricted Stock Units 2023-12-01 4 M false 7016.00 0.00 D Class A Common Stock 7016.00 49110.00 D Restricted Stock Units 2023-12-01 4 M false 34379.00 0.00 D Class A Common Stock 34379.00 446935.00 D Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. /s/ Melissa Curtin, Attorney-in-Fact 2023-12-05